Zacks Industry Outlook Highlights Electromed, Globus Medical and Intuitive Surgical
ELMD, GMED and ISRG are leveraging GenAI, strong procedure growth and expanding markets as healthcare AI adoption accelerates.
More News
3 Medical Instrument Stocks Exploring GenAI to Tackle Industry Woes
GenAI is reshaping medical instruments as Electromed, Globus Medical and Intuitive Surgical navigate M&A and market pressures.
Is AnaptysBio (ANAB) Outperforming Other Medical Stocks This Year?
Here is how AnaptysBio, Inc. (ANAB) and Electromed, Inc. (ELMD) have performed compared to their sector so far this year.
Here's Why Investors Should Stay Neutral on Humana Stock for Now
HUM's Medicare growth, CenterWell expansion and strong cash flow support gains, but rising costs and high leverage keep caution in focus.
Electromed, Inc. (ELMD)'s Technical Outlook is Bright After Key Golden Cross
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
Electromed (ELMD) is an Incredible Growth Stock: 3 Reasons Why
Electromed (ELMD) possesses solid growth attributes, which could help it handily outperform the market.
Zacks.com featured highlights include Healthcare Services, Electromed, UMB Financial, Shell and MACOM Technology Solutions
Healthcare Services, Electromed, UMB Financial, Shell and MACOM Technology Solutions stand out for strong efficiency metrics.
What Makes Electromed (ELMD) a Good Fit for 'Trend Investing'
Electromed (ELMD) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
HCSG, ELMD, UMBF, SHEL and MTSI passed an efficiency screen based on turnover ratios, asset use and operating margin strength.
All You Need to Know About Electromed (ELMD) Rating Upgrade to Strong Buy
Electromed (ELMD) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.